Literature DB >> 8489266

Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.

R Martini1, M Murray.   

Abstract

Cytochrome P450-mediated 4-hydroxylation is an important pathway in the termination of the biological action of retinoids. Several purified mammalian hepatic P450s have been shown to catalyze the 4-hydroxylation of all-trans-retinoic acid (retinoic acid) in reconstituted enzyme systems, but the nature of the activity in untreated rat liver microsomes has not been defined. In the present study, microsomal retinoic acid 4-hydroxylation was characterized in untreated liver from rats of both sexes and after a series of induction treatments. Thus, dexamethasone and phenobarbital, but not beta-naphthoflavone or dimethyl sulfoxide, increased the activity in male and female rats. An immunoglobulin G (IgG) fraction raised against P450 3A1 decreased the rate of retinoic acid 4-hydroxylation in untreated rat hepatic microsomes, but IgG directed against the P450s 2C11, 2B1, and 2C6 were noninhibitory. In vivo administration of triacetyloleandomycin, which has been shown to form a metabolite intermediate complex with P450 3A, followed by potassium ferricyanide oxidation in vitro, reactivated retinoic acid 4-hydroxylation and androst-4-ene-3,17-dione 6 beta-hydroxylation similarly (to 154 and 152% of the respective activities in the absence of potassium ferricyanide). Finally, exogenous retinoic acid (60 mg/kg ip for three days) markedly increased the rate of retinoic acid 4-hydroxylation in hepatic microsomes from male and female rats (3.8- and 3.7-fold, respectively). This occurred without comparable increases in other P450 activities. Despite these findings, the age- and sex-related profiles of microsomal retinoic acid 4-hydroxylation were clearly different from those measured for other P450 activities. Thus, on the basis of xenobiotic pretreatment, developmental, and immunochemical studies, the enzyme(s) involved in constitutive retinoic acid 4-hydroxylation appears distinct from a number of well-described P450s in untreated and induced rat liver. The data are consistent with the partial involvement of P450(s) from the 3A subfamily in retinoic acid 4-hydroxylation, but it seems clear that P450s 3A1 and 3A2 do not participate in this activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489266     DOI: 10.1006/abbi.1993.1255

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Inhibition of retinol oxidation by ethanol in the rat liver and colon.

Authors:  A Parlesak; I Menzl; A Feuchter; J C Bode; C Bode
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos.

Authors:  H Fujii; T Sato; S Kaneko; O Gotoh; Y Fujii-Kuriyama; K Osawa; S Kato; H Hamada
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 3.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

Review 4.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Arachidonic acid-mediated cooxidation of all-trans-retinoic acid in microsomal fractions from human liver.

Authors:  L Nadin; M Murray
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 6.  Cytochrome P450s in the regulation of cellular retinoic acid metabolism.

Authors:  A Catharine Ross; Reza Zolfaghari
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

7.  Upregulation of cytochromes P450 2B in rat liver by orphenadrine.

Authors:  Michael Murray; Eva Fiala-Beer; Dylan Sutton
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity.

Authors:  G Fex; K Larsson; A Andersson; M Berggren-Söderlund
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

9.  Effect of carrageenan-induced granuloma on hepatic cytochrome P-450 isozymes in rats.

Authors:  J Muntané; V Longo; M T Mitjavila; P G Gervasi; M Ingelman-Sundberg
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

10.  Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

Authors:  B J Braakhuis; I Klaassen; B M van der Leede; J Cloos; R H Brakenhoff; M P Copper; T Teerlink; H F Hendriks; P T van der Saag; G B Snow
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.